CIM
BIIB icon

Calvert Investment Management’s Biogen BIIB Stock Holding History

Calvert Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-13,056
Closed -$3.7M – 87
2016
Q4 		$3.7M Sell
13,056
-506
-4% -$150K 0.14% 216
2016
Q3 		$4.25M Buy
13,562
+664
+5% +$197K 0.16% 187
2016
Q2 		$3.12M Buy
12,898
+474
+4% +$125K 0.13% 190
2016
Q1 		$3.23M Buy
12,424
+2,772
+29% +$732K 0.14% 145
2015
Q4 		$2.96M Buy
9,652
+834
+9% +$240K 0.13% 152
2015
Q3 		$2.57M Buy
8,818
+290
+3% +$95.8K 0.13% 140
2015
Q2 		$3.44M Sell
8,528
-2,118
-20% -$850K 0.15% 129
2015
Q1 		$4.5M Buy
10,646
+1,293
+14% +$510K 0.29% 101
2014
Q4 		$3.17M Buy
9,353
+765
+9% +$247K 0.22% 120
2014
Q3 		$2.84M Buy
8,588
+6,362
+286% +$2.1M 0.21% 125
2014
Q2 		$702K Sell
2,226
-84
-4% -$25.3K 0.05% 200
2014
Q1 		$707K Buy
2,310
+20
+0.9% +$6.35K 0.05% 196
2013
Q4 		$641K Hold
2,290
– – 0.05% 206
2013
Q3 		$551K Sell
2,290
-70
-3% -$15.7K 0.07% 207
2013
Q2 		$508K Buy
+2,360
New +$504K 0.07% 199

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Calvert Investment Management's BIIB Position: Q1 2017 in Review

Calvert Investment Management sold out of Biogen (BIIB) in Q1 2017, closing a stake of 13,056 shares — an estimated $3.7M sold.

Calvert Investment Management first reported a position in BIIB in Q2 2013 and held it in 15 quarters. The position peaked at $4.5M in Q1 2015. 1,019 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

  • Calvert Investment Management reported no remaining Biogen position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 13,056 Biogen shares in Q1 2017, an estimated $3.7M.
  • Calvert Investment Management first reported a position in Biogen in Q2 2013 and held it in 15 quarters.
  • Calvert Investment Management's Biogen position peaked at $4.5M in Q1 2015.
  • 1,019 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.